CDKN1A and Hodgkins lymphoma: Clinically, EBV+ HL cases exhibited lower p21^cip1/waf1 expression and had significantly worse two-year survival outcomes compared to EBV- cases, suggesting that EBER1′s anti-apoptotic effect contributes to treatment resistance and poorer prognosis [13,40,64,65,86].